UB
ANIP icon

UMB Bank’s ANI Pharmaceuticals ANIP Stock Holding History

UMB Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.86K Buy
95
+6
+7% +$481 ﹤0.01% 1998
2026
Q1 		$6.84K Sell
89
-7
-7% -$546 ﹤0.01% 1969
2025
Q4 		$7.58K Buy
96
+8
+9% +$693 ﹤0.01% 1914
2025
Q3 		$8.06K Buy
88
+12
+16% +$978 ﹤0.01% 1752
2025
Q2 		$4.96K Buy
76
+23
+43% +$1.5K ﹤0.01% 1823
2025
Q1 		$3.55K Buy
53
+20
+61% +$1.2K ﹤0.01% 1847
2024
Q4 		$1.82K Buy
33
+31
+1,550% +$1.78K ﹤0.01% 1960
2024
Q3 		$119 Sell
2
-5
-71% -$305 ﹤0.01% 2129
2024
Q2 		$446 Buy
7
+1
+17% +$65 ﹤0.01% 2087
2024
Q1 		$415 Buy
+6
New +$362 ﹤0.01% 2020

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UMB Bank's ANIP Position: Q2 2026 in Review

UMB Bank increased its ANI Pharmaceuticals (ANIP) stake by 6.7% in Q2 2026, buying an estimated $481 and bringing the position to 95 shares worth $7.86K. The position accounts for ﹤0.01% of the portfolio, ranked #1998.

UMB Bank first reported a position in ANIP in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.06K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • UMB Bank held 95 shares of ANI Pharmaceuticals worth $7.86K as of Q2 2026.
  • UMB Bank bought 6 ANI Pharmaceuticals shares in Q2 2026, an estimated $481.
  • ANI Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1998 holding.
  • UMB Bank first reported a position in ANI Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • UMB Bank's ANI Pharmaceuticals position peaked at $8.06K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.